Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview
- Second quarter total net product sales of $242.0 million, up 46% year-over-year
August 06, 2024 04:05 PM Eastern Daylight Time
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the second quarter ended June 30, 2024.
“In the second quarter of 2024, Acadia delivered $242.0 million in net product sales, highlighted by 11% year-over-year growth in NUPLAZID net sales and 11% sequential growth in DAYBUE net sales,” said Steve Davis, Chief Executive Officer. “Additionally, we are advancing enrollment in our Phase 3 trial in Prader-Willi syndrome and our Phase 2 / Phase 3 program in Alzheimer’s disease psychosis. With two successful commercial products, a strong pipeline of late and early-stage assets and a growing cash balance, Acadia is in a strong position to support our long-term growth.”
Company Updates
- The journal Med published clinical data from two open-label extension studies, LILAC-1 and LILAC-2, which showed that patients treated with DAYBUE™ (trofinetide) who completed these studies experienced improvement in Rett syndrome symptoms as measured by the Rett Syndrome Behaviour Questionnaire (RSBQ).
- Presented interim data from the open-label real-world LOTUS™ study at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting. LOTUS is an ongoing, open-label caregiver-reported study evaluating the efficacy and tolerability outcomes in patients with Rett syndrome treated with DAYBUE.
https://www.businesswire.com/news/home/20240806318039/en/
- Forums
- ASX - By Stock
- Acadia
Acadia Pharmaceuticals Reports Second Quarter 2024 Financial...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 555 | $17.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.00 | 1600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 555 | 17.950 |
2 | 279 | 17.940 |
1 | 5000 | 17.500 |
1 | 60 | 17.200 |
1 | 100 | 17.150 |
Price($) | Vol. | No. |
---|---|---|
14.000 | 1600 | 1 |
14.590 | 400 | 1 |
14.630 | 251 | 2 |
14.730 | 365 | 3 |
14.890 | 60 | 7 |
Last trade - 11.18am 07/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable